Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,085 across all filing types
Latest filing 2020-04-27 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
2019年度监事会工作报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2019年度监事会工作报告" which translates to "2019 Supervisory Board Work Report". It details the supervisory board's activities, evaluations, and opinions on the company's 2019 operations, financial status, internal controls, and compliance with laws and regulations. It includes summaries of meetings, oversight of financial reports, and internal control evaluations. The document is a comprehensive report from the supervisory board on the company's governance and oversight activities for the year 2019. It is not an announcement or a brief summary but a detailed report on supervisory activities and opinions. This fits best under the category of Audit Report / Information (AR), as it includes audit-related oversight and supervisory board evaluations, but is not a full Annual Report (10-K) or a Management Discussion & Analysis (MDA). The length (4242 characters) and content confirm it is a full report rather than a short announcement or certification. Therefore, the classification is AR with high confidence. FY 2019
2020-04-27 Chinese
2019年年度报告
Annual Report Classification · 100% confidence The document is titled as the "2019 年年度报告全文" which translates to "2019 Annual Report Full Text". It contains detailed sections typical of an annual report such as company overview, financial data, business summary, management discussion and analysis, corporate governance, and financial statements. The document length is about 15,000 characters, indicating a full report rather than a brief announcement. It includes comprehensive financial figures, business operations, risk factors, and future outlook, which are characteristic of an official yearly report covering company activity and full financial performance. Therefore, this document fits the definition of an Annual Report (10-K). FY 2019
2020-04-27 Chinese
关于召开2019年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2019 Annual General Meeting (AGM) of the company 西藏易明西雅医药科技股份有限公司. It includes information about the meeting date, location, voting methods (both in-person and online), agenda items to be discussed and voted on (including the 2019 annual report, financial statements, board and supervisory reports, audit firm reappointment, capital changes, and profit distribution plan), registration procedures, and proxy voting instructions. The document does not contain the actual annual report or financial statements but rather serves as a formal notification to shareholders about the AGM and the matters to be considered. This fits the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting, or notices about the AGM itself. The document length is about 4940 characters, which is consistent with a detailed AGM notice rather than a full annual report or other filings. Therefore, the correct classification is AGM Information (AGM-R).
2020-04-27 Chinese
关于回购注销2019年限制性股票激励计划部分限制性股票的公告
Transaction in Own Shares Classification · 95% confidence The document is an official announcement from a company regarding the repurchase and cancellation of restricted stock under a 2019 restricted stock incentive plan. It details the reasons for the repurchase, the number of shares involved, the price, the approval process, and the impact on the company's share capital structure. The document includes board and supervisory committee meeting resolutions, independent director opinions, and legal opinions. It is not a full financial report, earnings release, or management discussion, but rather a specific corporate action announcement related to share repurchase and cancellation of restricted stock. This fits best under the category of Transaction in Own Shares (POS), which covers company buybacks or cancellations of its own shares.
2020-04-27 Chinese
关于续聘会计师事务所的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the reappointment of the auditing firm (立信会计师事务所) for the fiscal year 2020. It details the background of the auditing firm, the qualifications of the audit team, and the approval process by the board, audit committee, independent directors, and supervisory board. It explicitly states that the reappointment proposal will be submitted to the 2019 annual shareholders meeting for approval. The document does not contain any actual financial statements or audit reports but is rather a formal announcement about the auditor appointment process. The document length is 3549 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as an Audit Report / Information announcement (AR) because it relates to audit matters but is not the audit report itself. However, since it is an announcement about the auditor appointment and not the audit report or audit results, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about audit firm reappointment. It is not a full Annual Report (10-K), nor an Audit Report (AR) which would contain audit opinions and financial statements. It is not a Report Publication Announcement (RPA) because it does not announce the publication of a report but the reappointment of the auditor. Hence, the most appropriate classification is Regulatory Filings (RNS).
2020-04-27 Chinese
关于使用部分闲置募集资金和自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a listed company regarding the use of idle raised funds and own funds for cash management. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, details board and supervisory committee approvals, and provides specifics on investment amounts, types, and risk controls. The document does not contain financial statements or detailed financial results but rather discloses the company's decision and plan to invest idle funds in safe, liquid financial products. It is a regulatory announcement about capital management activities, not a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP). The document length is about 5,044 characters, which is sufficient for a detailed announcement but not a full report like an annual or interim report. Hence, the classification is CAP with high confidence.
2020-04-27 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.